(Q41137774)

27 September 2017

1 reference

title

Ocular toxicity and cancer chemotherapy. A review (English)

1 reference

27 September 2017

al-Tweigeri T

1

1 reference

27 September 2017

Nabholtz JM

series ordinal

2

1 reference

27 September 2017

Mackey JR

series ordinal

3

1 reference

27 September 2017

language of work or name

English

0 references

publication date

1 October 1996

1 reference

27 September 2017

1 reference

27 September 2017

volume

78

1 reference

27 September 2017

issue

7

1 reference

27 September 2017

page(s)

1359-1373

1 reference

Blurring of vision. A previously undescribed complication of cyclophosphamide therapy

27 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Blurring of vision due to ifosfamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Cataract after busulphan treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Sicca Syndrome in a Patient With Toxic Reaction to Busulfan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Intra-arterial BCNU chemotherapy for treatment of malignant gliomas of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Ophthalmic and central nervous system complications following intracarotid BCNU (Carmustine).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Visual abnormalities following nitrosourea treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

1,-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (methyl CCNU) and adriamycin combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Ocular and orbital toxicity following intracarotid injection of BCNU (carmustine) and cisplatinum for malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Limitations of high dose intra-arterial 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) chemotherapy for malignant gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Optic neuroretinitis in association with BCNU and procarbazine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Supraophthalmic intracarotid infusion of BCNU for malignant glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Optic nerve degeneration caused by supraophthalmic carotid artery infusion with cisplatin and ACNU. Case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Combination Chemotherapy as an Adjuvant Treatment in Operable Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Cisplatin-associated cortical blindness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Blindness associated with high-dose carboplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

The toxicity of cytarabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Blindness during remission in two patients with acute lymphoblastic leukemia.A possible complication of multimodality therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Photosensitivity Due to a Fluorouracil Derivative

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Cicatricial ectropion secondary to 5-fluorouracil therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Surgical treatment of punctal-canalicular fibrosis from 5-fluorouracil therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

2'-Deoxycoformycin (pentostatin) for lymphoid malignancies. Rational development of an active new drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Ocular complications of vincristine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Retinal changes induced by treatment with vincristine and vinblastine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Vincristine-induced neuropathy: A clinical study of fifty leukemic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Blindness and vincristine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Transient cortical blindness secondary to vincristine therapy in childhood malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Photopsia during 3-hour paclitaxel administration at doses > or = 250 mg/m2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Optic nerve disturbances: a new form of paclitaxel neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Ocular side effects of cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Serious complications of topical mitomycin-C after pterygium surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

21 January 2018

Tamoxifen retinopathy.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Clear evidence that long-term, low-dose tamoxifen treatment can induce ocular toxicity. A prospective study of 63 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Ocular complications of systemic cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Ocular effects of topical and systemic corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Toxoplasmosis. Clinical experiences in a cancer hospital.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Toxoplasmosis complicating malignancy. Experience at the National Cancer Institute.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Effect of corticosteroids on cataract formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Posterior subcapsular cataracts in steroid-requiring asthmatic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Pseudotumor Cerebri Associated With Corticosteroid Therapy in an Adult

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Benign intracranial hypertension during etretinate therapy for mycosis fungoides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Abnormal retinal function associated with fenretinide, a synthetic retinoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Ocular complications of bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Multiple cotton wool spots following bone marrow transplantation for treatment of acute lymphatic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Deoxycoformycin-induced response in chronic lymphocytic leukaemia: deoxyadenosine toxicity in non-replicating lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

The treatment of human cancer with intra-arterial nitrogen mustard, methylbis (2-chloroethyl) amine hydrochloride, utilizing a simplified catheter technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Lens changes in chronic granulocytic leukemia. Possible relationship to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Interference with cell proliferation and induction of polyploidy in rat lens epithelium during prolonged myleran treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Ocular toxicity associated with high-dose carmustine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Prevention of ocular toxicity of carmustine (BCNU) with supraophthalmic intracarotid infusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Peripheral neuropathy and ophthalmologic toxicity after treatment with cis-dichlorodiaminoplatinum II

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Seizures and transient cortical blindness associated with cis-platinum (II) diamminedichloride (PDD) therapy in a thirty-year-old man

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Transient left homonymous hemianopsia and encephalopathy following treatment of testicular carcinoma with cisplatinum, vinblastine, and bleomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Neurotoxic effects of cisplatin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Retinal toxicity after high-dose cisplatin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Ocular and orbital toxicity after intracarotid cisplatin therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Ophthalmic toxicity during carboplatin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Cytosine Arabinoside and Rosette Formation in Mouse Retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Corneal toxicity with systemic cytarabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Ocular toxicity from high-dose cytosine arabinoside

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Topical corticosteroid therapy for corneal toxicity from systemically administered cytarabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Lacrimation and 5-fluorouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Excessive Lacrimation From Fluorouracil Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Combined surgery, radiotherapy, and regional chemotherapy in carcinoma of the paranasal sinuses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Ocular irritation from high-dose methotrexate therapy: Pharmacokinetics of drug in the tear film

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Pentostatin in the treatment of advanced hairy cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Effectiveness of pentostatin (2'-deoxycoformycin) in refractory lymphoid neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Radiation-imitating chemicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Optic Neuropathy Presumably Caused by Vincristine Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Vincristine treatment of cancer in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Phase I study using desferrioxamine and iron sorbitol citrate in an attempt to modulate the iron status of tumor cells to enhance doxorubicin activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Mitomycin eye drops as treatment for pterygium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Tamoxifen retinopathy. A clinicopathologic report

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Retinopathy caused by treatment with tamoxifen in low dosage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Screening for ocular toxicity in asymptomatic patients treated with tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Reversible ocular toxicity related to tamoxifen therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Case report. Steroid exophthalmos

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Exophathalmos induced by steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Posterior subcapsular cataracts induced by corticosteroids in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Ocular toxicity from systemic drug therapy. An overview of clinically important adverse reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Adult cytomegalic inclusion retinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Posterior subcapsular cataracts in steroid treated children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

The association of cataract formation and systemic corticosteroid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

POSTERIOR LENTICULAR OPACITIES IN CHILDREN ON CORTICOSTEROID THERAPY

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Reversibility of corticosteroid-associated cataracts in children with the nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Cataracts after short-term corticosteroid treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

The electrolyte and water balance of the lens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Glaucoma induced by application of corticosteroids to the periorbital region

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Glaucoma from topically applied steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

EFFECT OF CORTICOSTEROIDS ON INTRAOCULAR PRESSURE AND FLUID DYNAMICS. I. THE EFFECT OF DEXAMETHASONE IN THE NORMAL EYE

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

CATARACTS AND TOPICAL CORTICOSTEROIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Ocular aspects of mycotic infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

PSEUDOTUMOR CEREBRI ASSOCIATED WITH PROLONGED CORTICOSTEROID THERAPY. REPORTS OF FOUR CASES.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Visual and cutaneous toxicity which occurs during N-(4-hydroxyphenyl) retinamide therapy for psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Interferon-associated retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Neurotoxic and other side effects of high-dose interferon in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Acute onset of ocular complications with interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

The eye in bone marrow transplantation. I. Clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

The eye in bone marrow transplantation. II. Histopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Ocular Manifestations of Graft-v-Host Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

The eye in bone marrow transplantation. III. Conjunctival graft-vs-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Cataracts after total body irradiation and marrow transplantation: a sparing effect of dose fractionation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Bone marrow transplantation and cataract development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Bone marrow transplant retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Microvasculopathy in the ocular fundus after bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Optic disc edema after bone marrow transplantation. Possible role of cyclosporine toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Orbital aspergillosis. Conservative debridement and local amphotericin irrigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

BW B759U for cytomegalovirus retinitis: intraocular drug penetration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

The eye in bone marrow transplantation. VI. Retinal complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1359%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

10.1002/(SICI)1097-0142(19961001)78:7<1359::AID-CNCR1>3.0.CO;2-G

21 January 2018

Identifiers

DOI

1 reference

27 September 2017

1 reference